Abstract

Background: Chondrosarcoma is a very rare brain tumor. Patients with mesenchymal chondrosarcoma have a worse prognosis and survival than other subtypes of brain chondrosarcoma. Case Report: A 29-year-old man underwent craniotomy because of a headache and blurred vision in his left eye lasting for 15 days. Pathologic examination revealed mesenchymal chondrosarcoma. Conclusion: Chondrosarcoma should be considered in the differential diagnoses of intracranial extra-axial hypo- and hypervascular tumors, especially in young patients. Surgical resection and radiotherapy are the preferred treatment for these patients.[GMJ.2016;5(4):219-24]

Highlights

  • Chondrosarcoma is a malignant neoplasm that produces a cartilaginous matrix

  • Radiological, and pathological features of a non-skull based intracranial extra-axial mesenchymal chondrosarcoma in a 29-year-old man

  • Table-1 shows a review of some literature about intracranial extraskeletal mesenchymal chondrosarcomas

Read more

Summary

Introduction

Chondrosarcoma is a malignant neoplasm that produces a cartilaginous matrix. It is a rare, high-grade malignant tumor that usually originates from soft and bone tissues. Radiological, and pathological features of a non-skull based intracranial extra-axial mesenchymal chondrosarcoma in a 29-year-old man. Case Presentation A 29-year-old man with no significant past medical history was referred to a neurosurgeon with a two-week history of a headache and blurry vision in his left eye. He had a headache on left side of the head that became progressively more severe. The second opinion of an expert pathology consultant confirmed the diagnosis of mesenchymal chondrosarcoma This tumor was nonreactive for epithelial membrane antigen (EMA) and did not label for CD34, Ck, GFAP, or smooth muscle actin (SMA).

Discussion
Location Imaging Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.